Unlocking the future of obesity treatment
Unlocking the future of obesity treatment
4 months ago
pharmaphorum.com
Biotech is back, with Craig Ackerman
Biotech is back, with Craig Ackerman
2 weeks ago
pharmaphorum.com
Hernexeos and what’s next, with Vicky Brown
Hernexeos and what’s next, with Vicky Brown
1 month ago
pharmaphorum.com
LSX2026: On promise and patience, with Hans Schambye
LSX2026: On promise and patience, with Hans Schambye
3 weeks ago
pharmaphorum.com
Allogeneic cell therapy isn’t dead, with Brian Culley
Allogeneic cell therapy isn’t dead, with Brian Culley
2 months ago
pharmaphorum.com
STEM AI: Delivering intelligent data-led HCP interactions
STEM AI: Delivering intelligent data-led HCP interactions
2 months ago
pharmaphorum.com
LSX2026: On a therapeutic vision for ocular disease, with Alexander Gebauer
LSX2026: On a therapeutic vision for ocular disease, with Alexander Gebauer
3 weeks ago
pharmaphorum.com
Astellas’ banner year and focused R&D strategy, with Adam Pearson
2 months ago
pharmaphorum.com
Lilly partners with Sidekick in digital health alliance
Jun 16, 2022
pharmaphorum.com
In pursuit of a cure for cancer: An ASCO 2025 discussion with Dr Danny Nguyen
9 months ago
pharmaphorum.com
Veeva Commercial Summit: On AI, content, and MLR Review with Emma Hyland
5 months ago
pharmaphorum.com
ESMO25: On getting ahead of cancer, with J&J's Henar Hevia & Carolyn Sousa
6 months ago
pharmaphorum.com
ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bladder cancer treatment
10 months ago
pharmaphorum.com
Regeneron gets long-awaited FDA okay for myeloma drug
9 months ago
pharmaphorum.com
AbbVie’s ASCO 2025 ADC breakthroughs: Transforming oncology with Temab-A ABBV-706 & PVEK
10 months ago
pharmaphorum.com
On the forefront of healthcare change, turning innovative science into value for patients: Astellas at ASCO 2025
9 months ago
pharmaphorum.com
Direct-to-patient is more than just telehealth – with EVERSANA’s Faruk Abdullah
Apr 4, 2025
pharmaphorum.com
Pfizer is first big pharma to tap Truveta's real-world data platform
Jun 22, 2022
pharmaphorum.com
Regeneron at ASCO 25: Advancing multiple myeloma treatment
10 months ago
pharmaphorum.com
Johnson & Johnson, ASCO 2025: Redefining global cancer care
9 months ago
pharmaphorum.com
Bridging research and clinical guidelines – interactive strategies for medical affairs success
Apr 7, 2025
pharmaphorum.com
BioNTech’s ASCO 2025 oncology advances: New data on bispecific antibodies, ADCs & mRNA immunotherapies
10 months ago
pharmaphorum.com
Pharma gets social – LillyPad provides platform for Lilly's corporate engagement
Jul 20, 2012
pharmaphorum.com
The evolution of real-world evidence
2 months ago
pharmaphorum.com
See more